NCT06757829Recruiting
Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENS
Pulmonary Functions in Sickle Cell Disease: Response of Adding Acu-TENS to Inspiratory Muscle Training
Source: ClinicalTrials.gov · Last updated 3 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
pulmonary complications are common in sickle cell disease patients. Respiratory training using inspiratory muscle trainer (IMT) is usually a good choice to improve these complications. Recently, acupuncture like transcutaneous electrical nerve stimulation (AC-tens) may also improve these complications.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 26 Dec 2024
- Start date
- 15 Dec 2024
- Primary completion date
- 1 May 2025
- Lead sponsor
- Cairo University
- Diseases
- Sickle cell disease
- NCT number
- NCT06757829
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 15 Dec 2024 to the primary completion date, 1 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with any systemic or chest or renal or hepatic or neurological diseases
Other
- women with lactation or pregnancy
- patients atacks of vasoocclusive crisis
Who the study is looking for
- sickle cell disease patients
- non obese patients
Age in the registry: 20 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Physical Therapy, Cairo University Coordinator of this site? Confirm its status | Dokki | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.